BioTech 365

AUGUST 6, 2020

Avacta appoints BBI Solutions as manufacturing partner for the rapid SARS-CoV-2 antigen test being developed with Cytiva CAMBRIDGE, England & WETHERBY, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it … Continue reading →

Manufacturing 52

Manufacturing Reagent Development 52

BioPharma Reporter

FEBRUARY 21, 2023

Donaldson Company will acquire Isolere Bio: an early-stage biotech that develops novel and proprietary âIsoTagâ reagents and accompanying filtration processes used for the purification and streamlined manufacturing of biopharmaceuticals.

Reagent 52

Reagent Manufacturing Development 52

BioTech 365

SEPTEMBER 2, 2020

Manufacturing agreement with Abingdon Health for Avacta’s rapid COVID-19 saliva test WETHERBY & CAMBRIDGE, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into an agreement with Abingdon … Continue reading → (..)

Manufacturing 52

Manufacturing Reagent Development 52

Roots Analysis

AUGUST 29, 2023

Cell therapy consumables are materials which are used in the manufacturing of cell therapies, however, do not form a part of the final product. Raw materials used for the production of cell therapies include culture media, growth factors, extracellular matrices and reagents.

Reagent 52

Reagent Manufacturing Production Containment 52

Drug Discovery World

MARCH 27, 2023

Learn more about the trends, insights, and perspectives from ACROBiosystems as a manufacturer of cell therapy reagents, including topics like: CAR-NK research Developing new CAR constructs Evaluation CAR expression detection Role of GMP Manufacturing in cell therapy Download now.

Reagent 52

Reagent Manufacturing Development Research 52

Drug Discovery World

OCTOBER 1, 2022

With an unrivalled research product portfolio and end-to-end manufacturing services, we are science led and customer focused to solve problems and deliver key reagents across complex chemicals, peptides and key biologics all from one trusted partner. Biosynth is at the edge of innovation.

Reagent 52

Reagent Life Science Manufacturing Production 52

FDA Law Blog

JANUARY 4, 2023

Brevig, Senior Regulatory Device and Biologics Expert — On December 7, 2022, FDA’s Center for Biologics Evaluation and Research (CBER) and the Office of Tissues and Advanced Therapies (OTAT) held a town hall to answer questions related to cell therapy and tissue-engineered products chemistry, manufacturing, and contr­­ols (CMC).

Reagent 59

Reagent Manufacturing Production Gene Therapy 59

Drug Discovery World

SEPTEMBER 25, 2023

IDT will stock and sell three additional research use only (RUO) and current good manufacturing practice (cGMP) CRISPR nucleases with unique performance characteristics, manufactured by Aldevron, to provide researchers with an accelerated path to the clinic.

Genome 52

Genome Genomics Gene Editing Medicine 52

Drug Discovery World

MARCH 27, 2023

Cell therapy research has never been more exciting with all of the research ongoing.

Reagent 52

Reagent Manufacturing Development Drugs 52

Drug Discovery World

AUGUST 11, 2023

GenScript Biotech and T-MAXIMUM Biotech have formed a strategic collaboration to develop T-MAXIMUM’s CAR-T cell therapy using GenScript’s CRISPR nucleic acid reagents. GenScript will provide various CRISPR reagents to support the development of the universal CAR-T products from discovery to commercialisation.

Reagent 52

Reagent Development Gene Editing Production 52

Drug Discovery World

NOVEMBER 22, 2022

The latest range of antigens can be used in immunoassay development and as immunogens, and includes reagents for both influenza A and B. . The post New range of influenza antigens for vaccine development appeared first on Drug Discovery World (DDW).

Vaccination 52

Vaccination Vaccine Development Reagent 52

Pharmaceutical Technology

SEPTEMBER 14, 2022

The increasing demand for API peptide products is in turn increasing the demand for peptide API manufacturers who also offer contract marketing services. Peptide API products have become popular due to their proven pharmacological value and favourable safety profiles. Discover the top API protein and peptide companies in contract marketing.

Protein 130

Protein Marketing Manufacturing Reagent 130

Pharmaceutical Technology

SEPTEMBER 1, 2022

While a significant proportion of this increase is due to the volume of lateral flow tests (LFTs) manufactured to perform mass screening of populations for Covid-19 over the last two years, this trend towards POC diagnostics is positive news. Manufacturing challenges.

Manufacturing 130

Manufacturing Bacterium Reagent Production 130

Pharmaceutical Technology

APRIL 3, 2023

The deal will see Polyplus join the German life science group’s portfolio allowing the latter to leverage expertise in transfection reagents and plasmid DNA for gene therapy. The company has been recently focusing on plasmid design and manufacturing through acquisitions of Xpress Biologics this year and e-Zyvec in 2022.

Gene Therapy 246

Gene Therapy Gene DNA Reagent 246

Drug Discovery World

MAY 7, 2024

mAb production involves extensive, complicated manufacturing operations with many biological raw materials that require detailed procedures and advanced technologies to ensure the quality and stability of the final product. As a result, single-use technologies were explored as a more sustainable approach to mAb manufacturing.

Antibody 59

Antibody Production Manufacturing Engineer 59

Drug Discovery World

JANUARY 30, 2024

He said: “Increasing the level of automation and standardisation is not only the way to reduce manufacturing costs, but also paves the way for follow-on approvals once a platform technology is part of an approval.  One option is that manufacturers will need to provide a product guarantee or refund the cost in a pay-for-performance model.

Gene Therapy 71

Gene Therapy Manufacturing Gene Clinical Trials 71

The Pharma Data

OCTOBER 14, 2020

This achievement provides additional assurances to our customers that critical components for their processes are designed and manufactured to meet their exacting requirements. This certification is widely recognized internationally as a standard for quality management systems related to medical devices and related services.

Manufacturing 40

Manufacturing Reagent Gene Therapy Protein 40

BioTech 365

SEPTEMBER 2, 2020

Ready-to-use kit enables rapid adeno-associated virus (AAV) titer determinations during the manufacture of AAV vectors UPPSALA, Sweden–(BUSINESS WIRE)–Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction … Continue (..)

Protein 52

Protein Gene Therapy Reagent Gene 52

pharmaphorum

NOVEMBER 26, 2020

It’s hoping to pick up clients in a range of sectors requiring regular human contact such as logistics, facilities management, education and manufacturing.

Reagent 93

Reagent Vaccination Vaccine Development 93

Drug Discovery World

AUGUST 11, 2023

The top stories: BlueRock and bit.bio sign Treg therapies discovery deal Bayer subsidiary BlueRock Therapeutics and bit.bio have announced a collaboration to discover and manufacture regulatory T cell (Treg) based therapies. The post This week in drug discovery (7-11 August) appeared first on Drug Discovery World (DDW).

Gene Therapy 52

Gene Therapy Drugs Clinical Trials Clinical Trials 52

Roots Analysis

FEBRUARY 21, 2022

Moreover, the manual protocols require extensive manipulation, costly reagents and long duration of skilled genomic library production. Nanoparticles Contract Manufacturing. For further information on this domain, check out the report –.

Marketing 52

Marketing Gene Sequencing DNA Genome 52

The Pharma Data

MAY 17, 2021

Academic centers should establish risk management programs to successfully commercialize cell and gene therapy products and to be a viable partner with contract research organizations (CROs) and manufacturers in developing these therapies. . Euro Convergence Programme. . © 2021 Regulatory Affairs Professionals Society.

Development 52

Development Gene Therapy Manufacturing Gene 52

The Pharma Data

JANUARY 24, 2021

25, 2021 (GLOBE NEWSWIRE) — Calibre Scientific is pleased to announce the acquisition of AIT France (“AIT”), a manufacturer and distributor of innovative consumables for analytical chemistry and chromatography. LOS ANGELES, Jan. Headquartered in Paris, France, AIT supplies public and private researchers and pharmaceutical laboratories.

Life Science 52

Life Science Reagent Manufacturing Production 52

Drug Discovery World

OCTOBER 3, 2022

Biosynth are experts in complex chemistry, peptides and key biological raw materials, providing more than half a million research products plus end-to-end manufacturing including discovery, optimisation, and scale up. Biosynth can ensure your project succeeds first time, with innovative expertise across chemistry and peptides.

Production 52

Production Life Science Manufacturing Research 52

The Pharma Data

MAY 4, 2021

The ban on the importation, manufacture, packing, sale, supply, possession, administration or use of unapproved COVID-19 vaccines therefore applies to all other vaccines, as well as to parallel imports of Comirnaty. Days after the media reports, CDSCO asked manufacturers and importers of tests and reagents to operate at maximum capacity.

Vaccination 52

Vaccination Vaccine Manufacturing Medicine 52

Drug Discovery World

JANUARY 10, 2023

We are vertically-integrated from immunisation through manufacturing and validation. Our catalog of over 6,500+ primary antibodies, 1,200+ secondary antibodies, and 50+ ELISA kits includes reagents for multiplex IF, flow cytometry, and more in fields including immunology, oncology, and neuroscience.

Antibody 52

Antibody Protein Reagent Scientist 52

XTalks

JUNE 27, 2022

CerTest Biotec specializes in the development and manufacturing of in vitro diagnostic medical devices and has expertise in the detection of human diseases. The collaboration will involve BD helping develop and validate CerTest’s VIASURE Monkeypox CE/IVD molecular test on its BD MAX™ open system regent suite.

Development 83

Development In-Vitro Reagent Vaccination 83

Roots Analysis

AUGUST 15, 2023

These expression systems utilize bio machinery harvested from the lysate of disrupted cells for the manufacturing of a wide array of macromolecular and small molecule products. Overview of Cell Free Systems Cell-free systems are ­in-vitro platforms which allow occurrence of biochemical reactions in the absence of living cells.

Protein 52

Protein In-Vitro Production Reagent 52

The Pharma Data

MARCH 23, 2022

We are also donating reagents and consumables for automatic testing of up to 120,000 blood donations and 31,000 units for diabetes management. This latest donation demonstrates our commitment to meeting the need for Roche medicines and diagnostics in Ukraine whenever possible.

Medicine 52

Medicine In-Vitro Reagent Branding 52

The Pharma Data

DECEMBER 14, 2020

Description of the problem : WHO has received user feedback on an elevated risk for false SARS-CoV-2 results when testing specimens using RT-PCR reagents on open systems. . Manufacturers regularly review the design of their product, including labelling and IFU based on customer feedback.

Reagent 52

Reagent In-Vitro Production Regulation 52

Camargo

MAY 2, 2021

INTERACT meetings are intended for sponsors with an identified novel product (or product-derivation strategy) with unique safety profile challenges related to complex manufacturing technologies, innovative devices, or new testing methodologies. The meeting has several goals: Discuss issues critical to early product development.

Gene Therapy 155

Gene Therapy Gene Packaging Packaging 155

Drug Discovery World

MAY 16, 2023

Curbishley explains that as the wave of new therapies in development continues to increase, global pressures on manufacturing availability will become more acute. Manufacturability matters. Furthermore, providing the flexibility needed to ramp manufacturing up or down depending on demand cycles has become more critical.”

Gene Therapy 52

Gene Therapy Gene Manufacturing Marketing 52

Roots Analysis

FEBRUARY 23, 2022

In the past two years, close to 3,220 patents related to NGS library preparation kits and reagents have been filed / granted, indicating the heightened pace of innovation. Next Generation Sequencing (NGS) Library Preparation Kits. Strong Intellectual Property Portfolio. Our Social Media Platform. Web: [link]. LinkedIn: [link].

Genetics 52

Genetics DNA RNA Reagent 52

XTalks

AUGUST 18, 2020

Instead of RNA extraction, the Yale test involves use of a reagent that when mixed with a saliva sample and heated for a short period of time, releases the viral genome for subsequent detection with PCR. Having a test that requires less reagents and resources, such as the RNA extraction kits, increases capabilities for increased testing.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

The Pharma Data

OCTOBER 19, 2020

–( BUSINESS WIRE )– ZOLL Medical Corporation , an Asahi Kasei company that manufactures medical devices and related software solutions, and CAIRE, Inc., a leading oxygen supply manufacturer, today announced the signing of an exclusive distributor agreement. 20, 2020 13:00 UTC. CHELMSFORD, Mass.–( All rights reserved.

Reagent 52

Reagent Manufacturing Marketing Production 52

Drug Discovery World

SEPTEMBER 14, 2023

While some manufacturers offer the ability to create your own code for their devices, most machines can be run with little to no programming knowledge. If you perform all of your tasks manually, you may need to stop your initial run partway through, which means losing the reagents and samples with which you have already begun working.

Reagent 111

Reagent Life Science Scientist DNA 111

Drug Discovery World

SEPTEMBER 29, 2022

Minimising reagent consumption and costs. How much time to prepare sufficient materials and reagents for screening? During a 2021 webinar on optimising assay development for hit identification, a survey asked over 50 drug discovery scientists, “Which goal is the highest priority when developing a drug discovery assay?”.

Reagent 52

Reagent DNA Scientist Drugs 52